Commissioning

CCGs under strain again from generic drug prices

By Cordelia McGeown2019-03-26T04:34:00

drugs2

The number of generic drugs being sold above national tariff rose to its highest rate in over two years at the start of 2019, despite national efforts to cut this number.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here